Home › Companies › VERTEX PHARMACEUTICALS INC. › 2024-2025
Compiled from SEC Form N-PX filings and VERTEX PHARMACEUTICALS INC.’s Form 8-K (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore VERTEX PHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are VERTEX PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Sangeeta Bhatia | 224,220,115 | 1,944,293 | 77,828 | -- | 10,235,401 | Majority: yes |
| Elect Director: Lloyd Carney | 217,229,047 | 8,930,150 | 83,039 | -- | 10,235,401 | Majority: yes |
| Elect Director: Alan Garber | 222,204,608 | 3,955,764 | 81,864 | -- | 10,235,401 | Majority: yes |
| Elect Director: Reshma Kewalramani | 225,606,258 | 543,398 | 92,580 | -- | 10,235,401 | Majority: yes |
| Elect Director: Michel Lagarde | 223,304,043 | 2,856,080 | 82,113 | -- | 10,235,401 | Majority: yes |
| Elect Director: Jeffrey Leiden | 220,817,175 | 5,347,122 | 77,939 | -- | 10,235,401 | Majority: yes |
| Elect Director: Diana McKenzie | 224,648,137 | 1,516,174 | 77,925 | -- | 10,235,401 | Majority: yes |
| Elect Director: Bruce Sachs | 211,582,895 | 14,580,875 | 78,466 | -- | 10,235,401 | Majority: yes |
| Elect Director: Jennifer Schneider | 225,303,813 | 859,650 | 78,773 | -- | 10,235,401 | Majority: yes |
| Elect Director: Nancy Thornberry | 223,303,176 | 2,862,344 | 76,716 | -- | 10,235,401 | Majority: yes |
| Elect Director: Suketu Upadhyay | 224,313,828 | 1,839,542 | 88,866 | -- | 10,235,401 | Majority: yes |
| Proposal 2: Based upon the following votes, the shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025: | 229,386,037 | 6,859,300 | 232,300 | -- | 0 | Majority: yes |
| Proposal 3: Based upon the following votes, the shareholders approved, on an advisory basis, the 2024 compensation program for the Company's named executive officers: | 208,886,386 | 17,048,300 | 307,550 | -- | 10,235,401 | Majority: yes |
| Proposal 4: Based upon the following votes, the shareholders did not approve a shareholder proposal regarding excessive golden parachutes: | 84,117,100 | 141,606,344 | 518,792 | -- | 10,235,401 | Majority: no |
Source: VERTEX PHARMACEUTICALS INC., Form 8-K — read the filing on EDGAR.
Each item below shows how the 1,176 asset managers that disclosed a VERTEX PHARMACEUTICALS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of VERTEX PHARMACEUTICALS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Meeting held 2025-05-14.
Combines 26 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Proposal 3: Based upon the following votes, the shareholders approved, on an advisory basis, the 2024 compensation program for the Company's named executive officers:”): 208,886,386 for, 17,048,300 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 256,967,767 outstanding shares: 81% for, 7% against (88% of the company cast a for/against vote).
The 1,132 asset managers below cast 94% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 63,097,045 | 56 | 0 | 0 | For |
| Vanguard | 28,286,327 | 3,160 | 0 | 0 | For |
| Fidelity | 17,516,287 | 0 | 0 | 0 | For |
| Capital Research Global Investors | 14,530,608 | 0 | 0 | 0 | For |
| State Street | 10,862,338 | 1,246 | 0 | 0 | For |
| BlackRock | 8,181,110 | 4,112 | 0 | 0 | For |
| JPMorgan | 7,759,340 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 5,682,808 | 0 | 0 | 0 | For |
| Wellington | 5,258,183 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,787,256 | 41,090 | 0 | 0 | For |
| JENNISON ASSOCIATES LLC | 4,332,984 | 5,224 | 0 | 0 | For |
| Loomis Sayles | 4,013,128 | 107,618 | 0 | 0 | For |
| AllianceBernstein | 3,917,634 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 3,904,210 | 0 | 0 | 0 | For |
| Charles Schwab | 3,415,050 | 0 | 0 | 0 | For |
| Parnassus | 2,977,453 | 0 | 0 | 0 | For |
| AMCAP FUND | 2,869,412 | 0 | 0 | 0 | For |
| Janus Henderson | 2,572,318 | 0 | 0 | 0 | For |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 2,350,405 | 0 | 0 | 0 | For |
| Northern Trust | 2,330,615 | 0 | 0 | 0 | For |
| Invesco | 2,145,059 | 0 | 0 | 0 | For |
| Victory Capital | 1,827,261 | 0 | 0 | 0 | For |
| Amundi | 0 | 1,685,423 | 0 | 0 | Against |
| Clearbridge Investments, LLC | 1,618,781 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,505,947 | 0 | 0 | 0 | For |
Showing the 25 largest of 1,132 asset managers. See all 1,132 in the interactive database.
Meeting held 2025-05-14.
Combines 10 wordings of this item as funds reported it.
37% Majority: no · of votes cast
VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Proposal 4: Based upon the following votes, the shareholders did not approve a shareholder proposal regarding excessive golden parachutes:”): 84,117,100 for, 141,606,344 against, per its Form 8-K (Item 5.07). FOR was not more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 256,967,767 outstanding shares: 33% for, 55% against (88% of the company cast a for/against vote).
The 251 asset managers below cast 18% of the shares they voted on this item FOR (21,950,894 for, 97,264,517 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 0 | 33,698,770 | 0 | 0 | Against |
| Vanguard | 4,265,261 | 22,425,055 | 0 | 0 | Against |
| Fidelity | 122,064 | 10,392,708 | 0 | 0 | Against |
| BlackRock | 18,816 | 8,166,406 | 0 | 0 | Against |
| INVESTMENT CO OF AMERICA | 0 | 3,904,210 | 0 | 0 | Against |
| State Street | 1,808 | 3,199,328 | 0 | 0 | Against |
| AMCAP FUND | 0 | 2,869,412 | 0 | 0 | Against |
| Charles Schwab | 0 | 1,688,811 | 0 | 0 | Against |
| T. Rowe Price | 0 | 1,601,535 | 0 | 0 | Against |
| JANUS INVESTMENT FUND | 1,505,947 | 0 | 0 | 0 | For |
| Victory Capital | 1,477,174 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 1,438,828 | 0 | 0 | Against |
| ADVISORS' INNER CIRCLE FUND | 0 | 1,425,730 | 0 | 0 | Against |
| Parnassus | 1,409,351 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 1,305,918 | 0 | 0 | Against |
| NEW ECONOMY FUND | 0 | 1,282,974 | 0 | 0 | Against |
| MFS | 0 | 1,263,931 | 0 | 0 | Against |
| Prudential/PGIM | 1,034,070 | 74,131 | 0 | 0 | For |
| Loomis Sayles | 978,540 | 0 | 0 | 0 | For |
| TIAA | 957,547 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 954,159 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 644,174 | 0 | 0 | 0 | For |
| Legg Mason | 589,937 | 0 | 0 | 0 | For |
| Invesco | 569,685 | 0 | 0 | 0 | For |
| Hartford | 553,726 | 0 | 0 | 0 | For |
Showing the 25 largest of 251 asset managers. See all 251 in the interactive database.
Meeting held 2025-05-14.
Combines 8 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Proposal 2: Based upon the following votes, the shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025:”): 229,386,037 for, 6,859,300 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 256,967,767 outstanding shares: 89% for, 3% against (92% of the company cast a for/against vote).
The 222 asset managers below cast 99.8% of the shares they voted on this item FOR (119,273,086 for, 155,889 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 33,698,770 | 0 | 0 | 0 | For |
| Vanguard | 26,687,866 | 2,450 | 0 | 0 | For |
| Fidelity | 10,514,772 | 0 | 0 | 0 | For |
| BlackRock | 8,185,222 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 3,904,210 | 0 | 0 | 0 | For |
| State Street | 3,201,069 | 67 | 0 | 0 | For |
| AMCAP FUND | 2,869,412 | 0 | 0 | 0 | For |
| Charles Schwab | 1,688,811 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,601,535 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,505,947 | 0 | 0 | 0 | For |
| Victory Capital | 1,477,174 | 0 | 0 | 0 | For |
| JPMorgan | 1,438,828 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 1,425,730 | 0 | 0 | 0 | For |
| Parnassus | 1,409,351 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,305,918 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,282,974 | 0 | 0 | 0 | For |
| MFS | 1,263,931 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,104,893 | 0 | 0 | 0 | For |
| Loomis Sayles | 978,540 | 0 | 0 | 0 | For |
| TIAA | 957,547 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 954,159 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 644,174 | 0 | 0 | 0 | For |
| Legg Mason | 589,937 | 0 | 0 | 0 | For |
| Invesco | 569,685 | 0 | 0 | 0 | For |
| Hartford | 553,726 | 0 | 0 | 0 | For |
Showing the 25 largest of 222 asset managers. See all 222 in the interactive database.
Meeting held 2025-05-14.
Combines 6 wordings of this item as funds reported it.
99.1% Majority: yes · of votes cast
VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Sangeeta Bhatia”): 224,220,115 for, 1,944,293 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 256,967,767 outstanding shares: 87% for, 0.8% against (88% of the company cast a for/against vote).
The 217 asset managers below cast 99.9% of the shares they voted on this item FOR (119,394,131 for, 20,150 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 33,698,770 | 0 | 0 | 0 | For |
| Vanguard | 26,690,316 | 0 | 0 | 0 | For |
| Fidelity | 10,514,772 | 0 | 0 | 0 | For |
| BlackRock | 8,185,222 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 3,904,210 | 0 | 0 | 0 | For |
| State Street | 3,201,136 | 0 | 0 | 0 | For |
| AMCAP FUND | 2,869,412 | 0 | 0 | 0 | For |
| Charles Schwab | 1,688,811 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,601,535 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,505,947 | 0 | 0 | 0 | For |
| Victory Capital | 1,477,174 | 0 | 0 | 0 | For |
| JPMorgan | 1,438,828 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 1,425,730 | 0 | 0 | 0 | For |
| Parnassus | 1,409,351 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,305,918 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,282,974 | 0 | 0 | 0 | For |
| MFS | 1,263,931 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,104,893 | 0 | 0 | 0 | For |
| Loomis Sayles | 978,540 | 0 | 0 | 0 | For |
| TIAA | 957,547 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 954,159 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 644,174 | 0 | 0 | 0 | For |
| Legg Mason | 589,937 | 0 | 0 | 0 | For |
| Invesco | 569,685 | 0 | 0 | 0 | For |
| Hartford | 553,726 | 0 | 0 | 0 | For |
Showing the 25 largest of 217 asset managers. See all 217 in the interactive database.
Meeting held 2025-05-14.
Combines 5 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Lloyd Carney”): 217,229,047 for, 8,930,150 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 256,967,767 outstanding shares: 85% for, 3% against (88% of the company cast a for/against vote).
The 217 asset managers below cast 97% of the shares they voted on this item FOR (116,114,616 for, 3,299,664 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 33,698,770 | 0 | 0 | 0 | For |
| Vanguard | 26,690,314 | 2 | 0 | 0 | For |
| Fidelity | 10,514,772 | 0 | 0 | 0 | For |
| BlackRock | 8,185,222 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 3,904,210 | 0 | 0 | 0 | For |
| State Street | 2,336 | 3,198,800 | 0 | 0 | Against |
| AMCAP FUND | 2,869,412 | 0 | 0 | 0 | For |
| Charles Schwab | 1,688,811 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,601,535 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,505,947 | 0 | 0 | 0 | For |
| Victory Capital | 1,477,174 | 0 | 0 | 0 | For |
| JPMorgan | 1,438,828 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 1,425,730 | 0 | 0 | 0 | For |
| Parnassus | 1,409,351 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,305,918 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,282,974 | 0 | 0 | 0 | For |
| MFS | 1,263,931 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,104,893 | 0 | 0 | 0 | For |
| Loomis Sayles | 978,540 | 0 | 0 | 0 | For |
| TIAA | 957,547 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 954,159 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 644,174 | 0 | 0 | 0 | For |
| Legg Mason | 589,937 | 0 | 0 | 0 | For |
| Invesco | 569,685 | 0 | 0 | 0 | For |
| Hartford | 553,726 | 0 | 0 | 0 | For |
Showing the 25 largest of 217 asset managers. See all 217 in the interactive database.
Meeting held 2025-05-14.
Combines 5 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Alan Garber”): 222,204,608 for, 3,955,764 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 256,967,767 outstanding shares: 86% for, 2% against (88% of the company cast a for/against vote).
The 217 asset managers below cast 99.9% of the shares they voted on this item FOR (119,371,853 for, 42,427 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 33,698,770 | 0 | 0 | 0 | For |
| Vanguard | 26,690,315 | 1 | 0 | 0 | For |
| Fidelity | 10,514,772 | 0 | 0 | 0 | For |
| BlackRock | 8,185,222 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 3,904,210 | 0 | 0 | 0 | For |
| State Street | 3,201,136 | 0 | 0 | 0 | For |
| AMCAP FUND | 2,869,412 | 0 | 0 | 0 | For |
| Charles Schwab | 1,688,811 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,601,535 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,505,947 | 0 | 0 | 0 | For |
| Victory Capital | 1,477,174 | 0 | 0 | 0 | For |
| JPMorgan | 1,438,828 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 1,425,730 | 0 | 0 | 0 | For |
| Parnassus | 1,409,351 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,305,918 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,282,974 | 0 | 0 | 0 | For |
| MFS | 1,263,931 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,104,893 | 0 | 0 | 0 | For |
| Loomis Sayles | 978,540 | 0 | 0 | 0 | For |
| TIAA | 957,547 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 954,159 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 644,174 | 0 | 0 | 0 | For |
| Legg Mason | 589,937 | 0 | 0 | 0 | For |
| Invesco | 569,685 | 0 | 0 | 0 | For |
| Hartford | 553,726 | 0 | 0 | 0 | For |
Showing the 25 largest of 217 asset managers. See all 217 in the interactive database.
Meeting held 2025-05-14.
Combines 5 wordings of this item as funds reported it.
99.7% Majority: yes · of votes cast
VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Reshma Kewalramani”): 225,606,258 for, 543,398 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 256,967,767 outstanding shares: 88% for, 0.3% against (88% of the company cast a for/against vote).
The 217 asset managers below cast 99.9% of the shares they voted on this item FOR (119,407,443 for, 6,836 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 33,698,770 | 0 | 0 | 0 | For |
| Vanguard | 26,690,316 | 0 | 0 | 0 | For |
| Fidelity | 10,514,772 | 0 | 0 | 0 | For |
| BlackRock | 8,185,222 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 3,904,210 | 0 | 0 | 0 | For |
| State Street | 3,201,136 | 0 | 0 | 0 | For |
| AMCAP FUND | 2,869,412 | 0 | 0 | 0 | For |
| Charles Schwab | 1,688,811 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,601,535 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,505,947 | 0 | 0 | 0 | For |
| Victory Capital | 1,477,174 | 0 | 0 | 0 | For |
| JPMorgan | 1,438,828 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 1,425,730 | 0 | 0 | 0 | For |
| Parnassus | 1,409,351 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,305,918 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,282,974 | 0 | 0 | 0 | For |
| MFS | 1,263,931 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,104,893 | 0 | 0 | 0 | For |
| Loomis Sayles | 978,540 | 0 | 0 | 0 | For |
| TIAA | 957,547 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 954,159 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 644,174 | 0 | 0 | 0 | For |
| Legg Mason | 589,937 | 0 | 0 | 0 | For |
| Invesco | 569,685 | 0 | 0 | 0 | For |
| Hartford | 553,726 | 0 | 0 | 0 | For |
Showing the 25 largest of 217 asset managers. See all 217 in the interactive database.
Meeting held 2025-05-14.
Combines 5 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Michel Lagarde”): 223,304,043 for, 2,856,080 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 256,967,767 outstanding shares: 87% for, 1% against (88% of the company cast a for/against vote).
The 217 asset managers below cast 99.9% of the shares they voted on this item FOR (119,407,267 for, 7,013 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 33,698,770 | 0 | 0 | 0 | For |
| Vanguard | 26,690,315 | 0 | 0 | 0 | For |
| Fidelity | 10,514,772 | 0 | 0 | 0 | For |
| BlackRock | 8,185,222 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 3,904,210 | 0 | 0 | 0 | For |
| State Street | 3,201,136 | 0 | 0 | 0 | For |
| AMCAP FUND | 2,869,412 | 0 | 0 | 0 | For |
| Charles Schwab | 1,688,811 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,601,535 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,505,947 | 0 | 0 | 0 | For |
| Victory Capital | 1,477,174 | 0 | 0 | 0 | For |
| JPMorgan | 1,438,828 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 1,425,730 | 0 | 0 | 0 | For |
| Parnassus | 1,409,351 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,305,918 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,282,974 | 0 | 0 | 0 | For |
| MFS | 1,263,931 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,104,893 | 0 | 0 | 0 | For |
| Loomis Sayles | 978,540 | 0 | 0 | 0 | For |
| TIAA | 957,547 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 954,159 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 644,174 | 0 | 0 | 0 | For |
| Legg Mason | 589,937 | 0 | 0 | 0 | For |
| Invesco | 569,685 | 0 | 0 | 0 | For |
| Hartford | 553,726 | 0 | 0 | 0 | For |
Showing the 25 largest of 217 asset managers. See all 217 in the interactive database.
Meeting held 2025-05-14.
Combines 6 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Jeffrey Leiden”): 220,817,175 for, 5,347,122 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 256,967,767 outstanding shares: 86% for, 2% against (88% of the company cast a for/against vote).
The 217 asset managers below cast 99.9% of the shares they voted on this item FOR (119,306,410 for, 107,870 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 33,698,770 | 0 | 0 | 0 | For |
| Vanguard | 26,690,315 | 1 | 0 | 0 | For |
| Fidelity | 10,514,772 | 0 | 0 | 0 | For |
| BlackRock | 8,185,222 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 3,904,210 | 0 | 0 | 0 | For |
| State Street | 3,201,106 | 30 | 0 | 0 | For |
| AMCAP FUND | 2,869,412 | 0 | 0 | 0 | For |
| Charles Schwab | 1,688,811 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,601,535 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,505,947 | 0 | 0 | 0 | For |
| Victory Capital | 1,477,174 | 0 | 0 | 0 | For |
| JPMorgan | 1,438,828 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 1,425,730 | 0 | 0 | 0 | For |
| Parnassus | 1,409,351 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,305,918 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,282,974 | 0 | 0 | 0 | For |
| MFS | 1,263,931 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,104,893 | 0 | 0 | 0 | For |
| Loomis Sayles | 978,540 | 0 | 0 | 0 | For |
| TIAA | 957,547 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 954,159 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 644,174 | 0 | 0 | 0 | For |
| Legg Mason | 589,937 | 0 | 0 | 0 | For |
| Invesco | 569,685 | 0 | 0 | 0 | For |
| Hartford | 553,726 | 0 | 0 | 0 | For |
Showing the 25 largest of 217 asset managers. See all 217 in the interactive database.
Meeting held 2025-05-14.
Combines 6 wordings of this item as funds reported it.
99.3% Majority: yes · of votes cast
VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Diana McKenzie”): 224,648,137 for, 1,516,174 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 256,967,767 outstanding shares: 87% for, 0.6% against (88% of the company cast a for/against vote).
The 217 asset managers below cast 99.9% of the shares they voted on this item FOR (119,399,414 for, 14,866 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 33,698,770 | 0 | 0 | 0 | For |
| Vanguard | 26,690,316 | 0 | 0 | 0 | For |
| Fidelity | 10,514,772 | 0 | 0 | 0 | For |
| BlackRock | 8,185,222 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 3,904,210 | 0 | 0 | 0 | For |
| State Street | 3,201,136 | 0 | 0 | 0 | For |
| AMCAP FUND | 2,869,412 | 0 | 0 | 0 | For |
| Charles Schwab | 1,688,811 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,601,535 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,505,947 | 0 | 0 | 0 | For |
| Victory Capital | 1,477,174 | 0 | 0 | 0 | For |
| JPMorgan | 1,438,828 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 1,425,730 | 0 | 0 | 0 | For |
| Parnassus | 1,409,351 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,305,918 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,282,974 | 0 | 0 | 0 | For |
| MFS | 1,263,931 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,104,893 | 0 | 0 | 0 | For |
| Loomis Sayles | 978,540 | 0 | 0 | 0 | For |
| TIAA | 957,547 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 954,159 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 644,174 | 0 | 0 | 0 | For |
| Legg Mason | 589,937 | 0 | 0 | 0 | For |
| Invesco | 569,685 | 0 | 0 | 0 | For |
| Hartford | 553,726 | 0 | 0 | 0 | For |
Showing the 25 largest of 217 asset managers. See all 217 in the interactive database.
Meeting held 2025-05-14.
Combines 6 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Bruce Sachs”): 211,582,895 for, 14,580,875 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 256,967,767 outstanding shares: 82% for, 6% against (88% of the company cast a for/against vote).
The 217 asset managers below cast 99.6% of the shares they voted on this item FOR (119,048,606 for, 365,675 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 33,698,770 | 0 | 0 | 0 | For |
| Vanguard | 26,690,314 | 2 | 0 | 0 | For |
| Fidelity | 10,514,772 | 0 | 0 | 0 | For |
| BlackRock | 8,185,222 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 3,904,210 | 0 | 0 | 0 | For |
| State Street | 3,201,069 | 67 | 0 | 0 | For |
| AMCAP FUND | 2,869,412 | 0 | 0 | 0 | For |
| Charles Schwab | 1,688,811 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,601,535 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,505,947 | 0 | 0 | 0 | For |
| Victory Capital | 1,477,174 | 0 | 0 | 0 | For |
| JPMorgan | 1,438,828 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 1,425,730 | 0 | 0 | 0 | For |
| Parnassus | 1,409,351 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,305,918 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,282,974 | 0 | 0 | 0 | For |
| MFS | 1,263,931 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,104,893 | 0 | 0 | 0 | For |
| Loomis Sayles | 978,540 | 0 | 0 | 0 | For |
| TIAA | 957,547 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 954,159 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 644,174 | 0 | 0 | 0 | For |
| Legg Mason | 589,937 | 0 | 0 | 0 | For |
| Invesco | 569,685 | 0 | 0 | 0 | For |
| Hartford | 553,726 | 0 | 0 | 0 | For |
Showing the 25 largest of 217 asset managers. See all 217 in the interactive database.
Meeting held 2025-05-14.
Combines 5 wordings of this item as funds reported it.
99.6% Majority: yes · of votes cast
VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Jennifer Schneider”): 225,303,813 for, 859,650 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 256,967,767 outstanding shares: 88% for, 0.4% against (88% of the company cast a for/against vote).
The 217 asset managers below cast 99.9% of the shares they voted on this item FOR (119,388,985 for, 25,295 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 33,698,770 | 0 | 0 | 0 | For |
| Vanguard | 26,690,316 | 0 | 0 | 0 | For |
| Fidelity | 10,514,772 | 0 | 0 | 0 | For |
| BlackRock | 8,185,222 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 3,904,210 | 0 | 0 | 0 | For |
| State Street | 3,201,136 | 0 | 0 | 0 | For |
| AMCAP FUND | 2,869,412 | 0 | 0 | 0 | For |
| Charles Schwab | 1,688,811 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,601,535 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,505,947 | 0 | 0 | 0 | For |
| Victory Capital | 1,477,174 | 0 | 0 | 0 | For |
| JPMorgan | 1,438,828 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 1,425,730 | 0 | 0 | 0 | For |
| Parnassus | 1,409,351 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,305,918 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,282,974 | 0 | 0 | 0 | For |
| MFS | 1,263,931 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,104,893 | 0 | 0 | 0 | For |
| Loomis Sayles | 978,540 | 0 | 0 | 0 | For |
| TIAA | 957,547 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 954,159 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 644,174 | 0 | 0 | 0 | For |
| Legg Mason | 589,937 | 0 | 0 | 0 | For |
| Invesco | 569,685 | 0 | 0 | 0 | For |
| Hartford | 553,726 | 0 | 0 | 0 | For |
Showing the 25 largest of 217 asset managers. See all 217 in the interactive database.
Meeting held 2025-05-14.
Combines 5 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Nancy Thornberry”): 223,303,176 for, 2,862,344 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 256,967,767 outstanding shares: 87% for, 1% against (88% of the company cast a for/against vote).
The 217 asset managers below cast 99.9% of the shares they voted on this item FOR (119,406,064 for, 8,216 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 33,698,770 | 0 | 0 | 0 | For |
| Vanguard | 26,690,315 | 0 | 0 | 0 | For |
| Fidelity | 10,514,772 | 0 | 0 | 0 | For |
| BlackRock | 8,185,222 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 3,904,210 | 0 | 0 | 0 | For |
| State Street | 3,201,136 | 0 | 0 | 0 | For |
| AMCAP FUND | 2,869,412 | 0 | 0 | 0 | For |
| Charles Schwab | 1,688,811 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,601,535 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,505,947 | 0 | 0 | 0 | For |
| Victory Capital | 1,477,174 | 0 | 0 | 0 | For |
| JPMorgan | 1,438,828 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 1,425,730 | 0 | 0 | 0 | For |
| Parnassus | 1,409,351 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,305,918 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,282,974 | 0 | 0 | 0 | For |
| MFS | 1,263,931 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,104,893 | 0 | 0 | 0 | For |
| Loomis Sayles | 978,540 | 0 | 0 | 0 | For |
| TIAA | 957,547 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 954,159 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 644,174 | 0 | 0 | 0 | For |
| Legg Mason | 589,937 | 0 | 0 | 0 | For |
| Invesco | 569,685 | 0 | 0 | 0 | For |
| Hartford | 553,726 | 0 | 0 | 0 | For |
Showing the 25 largest of 217 asset managers. See all 217 in the interactive database.
Meeting held 2025-05-14.
Combines 5 wordings of this item as funds reported it.
99.1% Majority: yes · of votes cast
VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Suketu Upadhyay”): 224,313,828 for, 1,839,542 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 256,967,767 outstanding shares: 87% for, 0.8% against (88% of the company cast a for/against vote).
The 217 asset managers below cast 99.9% of the shares they voted on this item FOR (119,399,999 for, 14,280 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 33,698,770 | 0 | 0 | 0 | For |
| Vanguard | 26,690,316 | 0 | 0 | 0 | For |
| Fidelity | 10,514,772 | 0 | 0 | 0 | For |
| BlackRock | 8,185,222 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 3,904,210 | 0 | 0 | 0 | For |
| State Street | 3,201,136 | 0 | 0 | 0 | For |
| AMCAP FUND | 2,869,412 | 0 | 0 | 0 | For |
| Charles Schwab | 1,688,811 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,601,535 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,505,947 | 0 | 0 | 0 | For |
| Victory Capital | 1,477,174 | 0 | 0 | 0 | For |
| JPMorgan | 1,438,828 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 1,425,730 | 0 | 0 | 0 | For |
| Parnassus | 1,409,351 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,305,918 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 1,282,974 | 0 | 0 | 0 | For |
| MFS | 1,263,931 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,104,893 | 0 | 0 | 0 | For |
| Loomis Sayles | 978,540 | 0 | 0 | 0 | For |
| TIAA | 957,547 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 954,159 | 0 | 0 | 0 | For |
| AB LARGE CAP GROWTH FUND INC | 644,174 | 0 | 0 | 0 | For |
| Legg Mason | 589,937 | 0 | 0 | 0 | For |
| Invesco | 569,685 | 0 | 0 | 0 | For |
| Hartford | 553,726 | 0 | 0 | 0 | For |
Showing the 25 largest of 217 asset managers. See all 217 in the interactive database.
Meeting held 2025-05-14.
92% Majority: yes · of votes cast
VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Proposal 3: Based upon the following votes, the shareholders approved, on an advisory basis, the 2024 compensation program for the Company's named executive officers:”): 208,886,386 for, 17,048,300 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 256,967,767 outstanding shares: 81% for, 7% against (88% of the company cast a for/against vote).
The 18 asset managers below cast 84% of the shares they voted on this item FOR (17,581 for, 3,467 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Focus Partners Wealth | 13,573 | 2,059 | 0 | 0 | For |
| LEAVELL INVESTMENT MANAGEMENT, INC. | 0 | 0 | 0 | 0 | Not Voted |
| MATTERN CAPITAL MANAGEMENT, LLC | 1,858 | 0 | 0 | 0 | For |
| WILLIAMSBURG INVESTMENT TRUST | 0 | 1,400 | 0 | 0 | Against |
| Simplify Exchange Traded Funds | 1,213 | 0 | 0 | 0 | For |
| Claret Asset Management Corp | 403 | 0 | 0 | 0 | For |
| VOISARD ASSET MANAGEMENT GROUP, INC. | 159 | 0 | 0 | 0 | For |
| Wallington Asset Management, LLC | 90 | 0 | 0 | 0 | For |
| Baker Avenue Asset Management, LP | 58 | 0 | 0 | 0 | For |
| Inlet Private Wealth, LLC | 56 | 0 | 0 | 0 | For |
| HARBOUR INVESTMENT MANAGEMENT LLC | 50 | 0 | 0 | 0 | For |
| Blue Fin Capital, Inc. | 32 | 0 | 0 | 0 | For |
| HOURGLASS CAPITAL, LLC | 25 | 0 | 0 | 0 | For |
| Blue Edge Capital, LLC | 24 | 0 | 0 | 0 | For |
| PEDDOCK CAPITAL ADVISORS, LLC | 21 | 0 | 0 | 0 | For |
| Williamson Legacy Group, LLC | 19 | 0 | 0 | 0 | For |
| COURIER CAPITAL LLC | 0 | 8 | 0 | 0 | Against |
| SCHOLTZ & COMPANY, LLC | 0 | 0 | 0 | 0 | -- |
Meeting held 2025-05-14.
34% fund support · no official result
The 14 asset managers below cast 34% of the shares they voted on this item FOR (227,555 for, 446,920 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Bellevue Group AG | 0 | 442,505 | 0 | 0 | Against |
| GuideStone | 71,283 | 0 | 0 | 0 | For |
| Erste Asset Management GmbH | 69,576 | 0 | 0 | 0 | For |
| Empower | 35,567 | 0 | 0 | 0 | For |
| iA Global Asset Management Inc. | 34,147 | 0 | 0 | 0 | For |
| HC CAPITAL TRUST | 12,418 | 0 | 0 | 0 | For |
| GreenFi Funds Trust | 0 | 4,415 | 0 | 0 | Against |
| CLEARWATER INVESTMENT TRUST | 3,400 | 0 | 0 | 0 | For |
| Maj Invest Holding A/S | 544 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST III | 258 | 0 | 0 | 0 | For |
| RWC Asset Management LLP | 234 | 0 | 0 | 0 | For |
| Colony Family Offices, LLC | 123 | 0 | 0 | 0 | For |
| UNIFIED SERIES TRUST | 5 | 0 | 0 | 0 | For |
| OARSMAN CAPITAL, INC. | 0 | 0 | 0 | 0 | -- |
Meeting held 2025-05-14.
All nominees (reported as one line). These filers reported the election of directors as a single line covering every nominee. It is not attributed to any one director, and no share total is shown for it.
Combines 2 wordings of this item as funds reported it.
100% fund support · no official result
The 6 asset managers below cast 100% of the shares they voted on this item FOR.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Green Alpha Advisors, LLC | 5,895 | 0 | 0 | 0 | For |
| WILLIAMSBURG INVESTMENT TRUST | 1,400 | 0 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 1,213 | 0 | 0 | 0 | For |
| HARBOUR INVESTMENT MANAGEMENT LLC | 550 | 0 | 0 | 0 | For |
| VOISARD ASSET MANAGEMENT GROUP, INC. | 159 | 0 | 0 | 0 | For |
| Williamson Legacy Group, LLC | 19 | 0 | 0 | 0 | For |
Meeting held 2024-05-15 (outside the 2024-2025 season's 1 July to 30 June window; reported in this season's filings).
Combines 3 wordings of this item as funds reported it.
91% Majority: yes · of votes cast
VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Proposal 3: Based upon the following votes, the shareholders approved, on an advisory basis, the 2023 compensation program for the Company's named executive officers:”): 202,098,575 for, 19,223,784 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 256,967,767 outstanding shares: 79% for, 7% against (86% of the company cast a for/against vote).
The 6 asset managers below cast 36% of the shares they voted on this item FOR (7,701 for, 13,940 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Knuff & Co LLC | 0 | 13,940 | 0 | 0 | Against |
| Americana Partners, LLC | 4,285 | 0 | 0 | 0 | For |
| COLDSTREAM CAPITAL MANAGEMENT INC | 2,185 | 0 | 0 | 0 | For |
| Ipswich Investment Management Co., Inc. | 1,153 | 0 | 0 | 0 | For |
| Seascape Capital Management | 78 | 0 | 0 | 0 | For |
| Echo45 Advisors LLC | 0 | 0 | 0 | 0 | -- |
Meeting held 2025-05-14.
100% fund support · no official result
The 5 asset managers below cast 100% of the shares they voted on this item FOR (1,419,632 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Union Investment Privatfonds GmbH | 1,260,519 | 0 | 0 | 0 | For |
| Cardano Risk Management B.V. | 71,540 | 0 | 0 | 0 | For |
| OSSIAM | 68,666 | 0 | 0 | 0 | For |
| Impact Asset Management GmbH | 12,210 | 0 | 0 | 0 | For |
| Union Investment Institutional GmbH | 6,697 | 0 | 0 | 0 | For |
Meeting held 2025-05-14.
92% Majority: yes · of votes cast
VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Proposal 3: Based upon the following votes, the shareholders approved, on an advisory basis, the 2024 compensation program for the Company's named executive officers:”): 208,886,386 for, 17,048,300 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 256,967,767 outstanding shares: 81% for, 7% against (88% of the company cast a for/against vote).
The 3 asset managers below cast 100% of the shares they voted on this item FOR (54 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Members Trust Co | 26 | 0 | 0 | 0 | For |
| Two Roads Shared Trust | 15 | 0 | 0 | 0 | For |
| Blue Sky Capital Consultants Group, Inc. | 13 | 0 | 0 | 0 | For |
Meeting held 2025-05-14.
Combines 2 wordings of this item as funds reported it.
100% fund support · no official result
The 2 asset managers below cast 100% of the shares they voted on this item FOR (41 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Members Trust Co | 26 | 0 | 0 | 0 | For |
| Two Roads Shared Trust | 15 | 0 | 0 | 0 | For |
Meeting held 2025-05-14.
92% Majority: yes · of votes cast
VERTEX PHARMACEUTICALS INC.’s own tally for this item (“Proposal 3: Based upon the following votes, the shareholders approved, on an advisory basis, the 2024 compensation program for the Company's named executive officers:”): 208,886,386 for, 17,048,300 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 256,967,767 outstanding shares: 81% for, 7% against (88% of the company cast a for/against vote).
The 2 asset managers below cast 100% of the shares they voted on this item FOR (788 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Empower | 638 | 0 | 0 | 0 | For |
| CHELSEA COUNSEL CO | 150 | 0 | 0 | 0 | For |
Ranked by the number of VERTEX PHARMACEUTICALS INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 256,967,767 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Capital Group | 24.55% |
| 2 | Vanguard | 11.01% |
| 3 | Fidelity | 6.82% |
| 4 | Capital Research Global Investors | 5.65% |
| 5 | State Street | 4.23% |
| 6 | BlackRock | 3.19% |
| 7 | JPMorgan | 3.02% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 2.21% |
| 9 | Wellington | 2.05% |
| 10 | T. Rowe Price | 1.88% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Capital World Investors | 10.00% | 13G |
| The Vanguard Group | 8.67% | DEF14A |
| BlackRock | 8.48% | 13F |
| Capital Research Global Investors | 8.23% | 13G |
| State Street | 4.59% | 13F |
| JPMorgan Chase | 3.02% | 13F |
| FMR (Fidelity) | 3.01% | 13F |
| Wellington Management | 2.12% | 13F |
| Norges Bank | 1.35% | 13F |
| Morgan Stanley | 1.33% | 13F |
Percentages above are of 256,967,767 shares outstanding, as reported by VERTEX PHARMACEUTICALS INC. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from VERTEX PHARMACEUTICALS INC.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At VERTEX PHARMACEUTICALS INC.'s shareholder meeting held 2025-05-14, in the 2024-2025 proxy season, 1,176 asset managers reported how they voted in their SEC Form N-PX filings, covering 16,542 separate fund positions. Their filings are grouped here into 22 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Advisory vote to approve named executive officer compensation. — FOR was 92% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: VERTEX PHARMACEUTICALS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission (filing date not recorded for this item).
VERTEX PHARMACEUTICALS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.